J-F Baurain - Service d’Oncologie Médicale des Cliniques Universitaires Saint-Luc, Université Catholique de Louvain

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 25 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

1024P Initial Clinical Results of BT-001, an Oncolytic Virus Expressing an Anti-Ctla4 Mab, Administered As Single Agent and in Combination with Pembrolizumab in Patients with Advanced Solid Tumors

S. Champiat, C. Lebbe,J-F. Baurain, A. Italiano,M. Sakkal, C. Spring-Giusti,N. Stojkowitz, M. Brandely, A. Sadoun, A. Ropenga, M. Semmrich, A. McAllister,M. Chisamore, P. Cassier

Annals of Oncology (2024)

引用0浏览0引用

737P Characterization of Tumor Response with Lenvatinib Plus Pembrolizumab (LEN + Pembro) in the ENGOT-en9/LEAP-001 Study

A. Danska-Bidzinska,V. Makker,V. Salutari, A. Ayhan, I. Romero, T. Levy, M. McCormack,J-F. Baurain, P. Mach,K.A. Cadoo, H. Mackay,M.L. Friedlander, A.D. Santin, B.M. Slomovitz, D.S. Miller, J. McKenzie, L. Yao,V. Khemka,A. Nogueira-Rodrigues, C. Marth

Annals of Oncology (2024)

引用0浏览0引用

Immune Checkpoint Inhibitor Refractory Colitis Leading to Total Colectomy in a Melanoma Patient

N. Baczewska, M. Philippart, J. Siplet,J-F. Baurain, L. Stainier, E. Laterre,L. Duck,J-C. Coche

Acta Gastro Enterologica Belgicano. 2 (2023): 371-373

引用0浏览0WOS引用

823P A Propensity Score Weighted Comparison of Tebentafusp or Pembrolizumab Versus Combination Ipilimumab and Nivolumab in Untreated Metastatic Uveal Melanoma

J. M. Piulats Rodriguez,S. Piperno-Neumann,P. Rutkowski,P. Nathan,J. C. Hassel,E. Espinosa,L. De la Cruz Merino,S. Ochsenreither,A. N. Shoushtari,M. Orloff,A. K. S. Salama,C. Watkins, H. Goodall,J-F. Baurain

Annals of Oncology (2022): S924-S924

引用1浏览0引用

Homologous Recombination Repair Deficiency (HRD) Testing in Newly Diagnosed Advanced-Stage Epithelial Ovarian Cancer: A Belgian Expert Opinion

I Vergote,H. Denys,S. Altintas,J. Kerger,J-F Baurain,V Bours, S. Henry,K. Van de Vijver,D. Lambrechts,C. Gennigens

Facts, views & vision in ObGyn（2022）

引用1浏览0WOS引用

881Tip A Multi-Centre, Open-Label Phase II Trial of the Combination of VB10.16 and Atezolizumab in Patients with Advanced or Recurrent, Non-Resectable HPV16 Positive Cervical Cancer

P. Hillemanns,J-F. Baurain,P. Blecharz,K. Lindemann, B. Nicolaisen, K. Schetne, A. B. Fredriksen, S. Torhaug

Annals of oncology（2020）

引用4浏览0引用

Influence Of Intraoperative Administration Of Ketorolac On The Prognosis Of Ovarian Cancer

M. Luyckx, C. Verougstraete,P. Forget, M. Jouret, M. Waterkeyn, F. Grandjean,J-F Baurain, J-P Van Gossum,J. Squifflet

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER（2019）

引用0浏览0引用

Loss of HLA Class I Expression and T-cell Infiltration or PD-L1 Expression Are Associated with Different Response Patterns to Pembrolizumab in Melanoma

A. Degraeuwe,N. van Baren,F. Cornelis,P. van Eeckhout,J-F. Baurain

Annals of Oncology (2018): viii450-viii450

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn